Jeffrey H. Lawson, MD, PhD

Original Contribution

Effectiveness of Glycerol Mono-oleate as a Biosealant

08/01/2008

Linda K. Shaw , MS;

Luther Milton ;

Jeffrey H. Lawson , MD, PhD;

Roberto J. Manson , MD;

Dana M. Giangiacomo , BS;

Lucy Fronheiser , MS;

George L. Adams , MD, MHS, MBA, FACC, FSCAI;

Shannon McCall , MD;

Roger Nightingale , PhD;

Vic Hasselblad , PhD;

Vascular access site complications are common following cardiac catheterization.1 These complications, as high as 14% of patients undergoing percutaneous coronary intervention (PCI), increase hospital length of stay and cost.2 Accordingly,...

Vascular access site...

08/01/2008

Journal of Invasive Cardiology

Interview

Jeffrey Lawson, MD, Describes Development of a Bioengineered Blood Vessel

03/03/2015

Jeffrey H. Lawson , MD, PhD;

Jeffrey Lawson, MD, of Duke University, discusses engineering of an implantable blood vessel from donor vascular cells. The technology has received US Food and Drug Administration fast-track designation for approval, and clinical trials are...

Jeffrey Lawson, MD, of Duke...

03/03/2015

Vascular Disease Management